Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 4237
  • Home
  • Print this page
  • Email this page

    Article Cited by others

BRIEF REPORT

Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye

Raghuram A, Saravanan V R, Narendran V

Year : 2007| Volume: 55| Issue : 6 | Page no: 460-462

   This article has been cited by
 
1 Antivascular endothelial growth factors in anterior segment diseases
Scholl, S., Kirchhof, J., Augustin, A.J.
Developments in Ophthalmology. 2010; 46: 133-139
[Pubmed]  [Google Scholar]
2 Intraocular injection of bevacizumab for rubeosis capsulare in a pseudophakic eye
J Rajagopal, A G Kamath, G G Kamath, M M Rao
Eye. 2010; 24(2): 384
[HTML Full text]  [Google Scholar] [DOI]
3 Intracameral bevacizumab for rubeotic glaucoma secondary to retinal vein occlusion
Simon P. Kelly, Kashif Qureshi, Shahram Kashani
International Ophthalmology. 2009; 29(6): 537-539
[Pubmed]  [Google Scholar] [DOI]
4 The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma
Gupta, V., Jha, R., Rao, A., Kong, G., Sihota, R.
European Journal of Ophthalmology. 2009; 19(3): 435-441
[Pubmed]  [Google Scholar]
5 Intra-cameral injection of Bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
Agarwal, M., Dubey, S.
Indian Journal of Ophthalmology. 2008; 56(3): 258-259
[Pubmed]  [Google Scholar]

 

Read this article